Chen, X., Yan, Y., Liu, Y., Yi, Q., & Xu, Z. (2024). Tabersonine enhances cisplatin sensitivity by modulating Aurora kinase A and suppressing epithelial–mesenchymal transition in triple-negative breast cancer. Pharmaceutical Biology, 62(1), 394. https://doi.org/10.1080/13880209.2024.2351934
Chicago-referens (17:e uppl.)Chen, Xi, Yuanliang Yan, Yuanhong Liu, Qiaoli Yi, och Zhijie Xu. "Tabersonine Enhances Cisplatin Sensitivity by Modulating Aurora Kinase A and Suppressing Epithelial–mesenchymal Transition in Triple-negative Breast Cancer." Pharmaceutical Biology 62, no. 1 (2024): 394. https://doi.org/10.1080/13880209.2024.2351934.
MLA-referens (9:e uppl.)Chen, Xi, et al. "Tabersonine Enhances Cisplatin Sensitivity by Modulating Aurora Kinase A and Suppressing Epithelial–mesenchymal Transition in Triple-negative Breast Cancer." Pharmaceutical Biology, vol. 62, no. 1, 2024, p. 394, https://doi.org/10.1080/13880209.2024.2351934.
